Bumper Offer - Urjas oil Just @ Rs. 1 X
Engaba 75 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Neuropathic Pain, Epilepsy, Anxiety. Secondary and off-label uses of Engaba 75 Mg Tablet have also been mentioned below.
The right dosage of Engaba 75 Mg Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Engaba 75 Mg Tablet as well, which are listed below. Usually, these side effects of Engaba 75 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Engaba 75 Mg Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Engaba 75 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Engaba 75 Mg Tablet related warnings section.
Other conditions have been mentioned below in the Engaba 75 Mg Tablet contraindications section.
Besides this, Engaba 75 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Engaba 75 Mg Tablet is not safe while driving, and is is not addictive in nature.
Engaba 75 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Engaba 75 Mg Tablet is used -
Moderate
Mild
Is the use of Engaba 75 Mg Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Engaba. It is best to stop taking Engaba immediately and inform your doctor if you notice any discomfort.
Is the use of Engaba 75 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Engaba. So it is adviced to consult the doctor before using it.
What is the effect of Engaba 75 Mg Tablet on the Kidneys?
Engaba may have mild side effects on the kidneys.
What is the effect of Engaba 75 Mg Tablet on the Liver?
Engaba is not harmful for the liver.
What is the effect of Engaba 75 Mg Tablet on the Heart?
Engaba is completely safe for the heart.
Engaba 75 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Engaba 75 Mg Tablet unless your doctor advises you to do so -
Is this Engaba 75 Mg Tablet habit forming or addictive?
Forming a habit of Engaba 75 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Engaba 75 Mg Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Engaba 75 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
Engaba 75 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Engaba 75 Mg Tablet
Taking Engaba 75 Mg Tablet with food is safe.
Interaction between Alcohol and Engaba 75 Mg Tablet
Consult your doctor before consuming alcohol while taking Engaba 75 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420